Literature DB >> 1537967

A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster.

R H Dworkin1, G Hartstein, H L Rosner, R R Walther, E W Sweeney, L Brand.   

Abstract

Although patients with chronic pain are often psychologically distressed, it has been difficult to determine whether this distress is an antecedent of chronic pain or whether it is caused by the experience of living with chronic pain. The aim of this investigation was to develop a method that would allow individuals who are at risk for the development of chronic pain to be studied before their pain has become chronic. Patients with acute herpes zoster were assessed with demographic, medical, pain, and psychosocial measures. Pain was assessed in follow-up interviews at 6 weeks and 3, 5, 8, and 12 months after these initial assessments. There were no significant differences between patients who developed short-term herpes zoster pain and patients who did not develop short-term pain for any of the measures at the initial assessment, except for one measure of pain intensity. Patients who developed chronic herpes zoster pain, however, had significantly greater pain intensity, higher state and trait anxiety, greater depression, lower life satisfaction, and greater disease conviction at the initial assessment than patients who did not develop chronic pain. In discriminant analyses, disease conviction, pain intensity, and state anxiety each made a unique contribution to discriminating patients who did and who did not develop chronic pain. This study demonstrates the feasibility of investigating psychosocial antecedents of the development of chronic pain by prospectively examining the longitudinal course of herpes zoster.

Entities:  

Mesh:

Year:  1992        PMID: 1537967     DOI: 10.1037//0021-843x.101.1.200

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  21 in total

1.  Risk factors for chronic pain following breast cancer surgery: a prospective study.

Authors:  Ellen L Poleshuck; Jennifer Katz; Carl H Andrus; Laura A Hogan; Beth F Jung; Dale I Kulick; Robert H Dworkin
Journal:  J Pain       Date:  2006-09       Impact factor: 5.820

Review 2.  The management of postherpetic neuralgia.

Authors:  D Bowsher
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

3.  Herpes zoster and postherpetic neuralgia: an examination of psychological antecedents.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2014-05

Review 4.  The Role of Psychosocial Processes in the Development and Maintenance of Chronic Pain.

Authors:  Robert R Edwards; Robert H Dworkin; Mark D Sullivan; Dennis C Turk; Ajay D Wasan
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

Review 5.  Herpes zoster and postherpetic neuralgia. Optimal treatment.

Authors:  R W Johnson
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 6.  Treatment of postherpetic neuralgia: an update.

Authors:  G E Kanazi; R W Johnson; R H Dworkin
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

7.  Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.

Authors:  S Helgason; G Petursson; S Gudmundsson; J A Sigurdsson
Journal:  BMJ       Date:  2000-09-30

8.  Natural history of pain following herpes zoster.

Authors:  Hans Gustav Thyregod; Michael C Rowbotham; Michelle Peters; Jessica Possehn; Marlene Berro; Karin Lottrup Petersen
Journal:  Pain       Date:  2006-10-27       Impact factor: 6.961

9.  Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors.

Authors:  Jo A Dalton; Melinda K Higgins; Andrew H Miller; Francis J Keefe; Fadlo R Khuri
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

Review 10.  Factors contributing to pain chronicity.

Authors:  Charlie K Wang; Jennifer Myunghae Hah; Ian Carroll
Journal:  Curr Pain Headache Rep       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.